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	 Benzofuroxan	 derivative	 (1a)	 reacts	 with	 the	 cyanoacetanilides	 (2a‐d)	 to	 give	 the
benzimidazole	 derivatives	 (3a‐d).	 Benzofuroxan	 (1b)	 reacts	 with	 rhodanine	 derivatives
(4a,b)	 in	 presence	 of	 sodium	 ethoxide	 to	 give	 the	 arylaminobenzoimidazole	 derivatives
(6a,b);	 while	 the	 last	 reaction	 afforded	 the	 thiazolidinone	 derivatives	 (8a,b)	 and	 the	 o‐
benzoquinone	 dioxime	 derivatives	 (9a,b)	 when	 it	 was	 repeated	 in	 the	 presence	 of	 sodium
acetate.	Moreover,	a	series	of	quinoxalinyl	1,4‐di‐N‐oxide	derivatives	were	prepared	starting
from	quinoxalin‐1,4‐di‐N‐oxide	derivatives	(10a‐c).	Plausible	mechanisms	to	account	 for	the
formation	of	the	products	are	discussed.	
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1.	Introduction	
	
Over	 the	 last	 three	 decades	 we	 have	 been	 involved	 in	 a	
program	 aiming	 to	 develop	 new	 simple	 procedures	 or	 novel	
precursors	 for	 the	 synthesis	 of	 heterocyclic	 compounds	 of	
biological	 interest	 from	 cheap	 laboratory	 available	 starting	
materials	 to	 be	 evaluated	 as	 biodegradable	 agrochemicals	 [1‐
8].	
Benzofuroxans	 display	 several	 biochemical	 and	
pharmacological	 properties	 and	 specific	 studies	were	devoted	
to	 these	 aspects	 [9‐11].	 Several	 authors	 have	 reported	 about	
the	biological	importance	of	quinoxaline	1,4‐dioxides	(QdNO's)	
since	 1940's.	 Classical	 and	 more	 recent	 methods	 of	 the	
synthesis	 of	 the	 quinoxaline	 1,4‐dioxides	 and	 some	 of	 their	
most	important	reactions	were	also	reported	[12,13].	
Furthermore	 quinoxaline	 1,4‐di‐N‐oxide	 derivatives	 were	
reported	to	exhibit	hypoxia‐selective	cytotoxins	and	anticancer	
activities	 [14,15]	 as	 well	 as	 mycobacterium	 tuberculostatic	
activities	 [16,17].	 In	view	of	 these	 facts	and	 in	continuation	of	
our	 earlier	 interest	 [18‐20],	we	 report	here	 the	 results	of	 our	
investigations	 on	 benzofuroxans	 1‐oxide	 (1a‐b)	 and	
quinoxaline	1,4‐di‐N‐oxide		(10a‐c)	derivatives	(Scheme	1).		
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Scheme	1	
2.	Experimental	
	
All	 melting	 points	 are	 recorded	 on	 Gallenkamp	 electric	
melting	point	apparatus	and	are	uncorrected.	The	IR	spectra	(υ,	
cm‐1;	 KBr)	 were	 recorded	 on	 Perkin	 Elmer	 Infrared	
Spectrophotometer	 Model	 157,	 Grating.	 The	 1H	 NMR	 spectra	
were	run	on	Varian	Spectrometer	at	200	MHz	using	TMS	as	an	
internal	reference	and	DMSO‐d6	as	solvent	and	chemical	shifts	
are	expressed	in	δ	(ppm).	The	mass	spectra	(EI)	were	run	at	70	
eV	 with	 Kratos	 MS	 equipment	 and/or	 a	 Varian	 MAT	 311	 A	
Spectrometer.	Elemental	analyses	were	carried	out	at	the	micro	
analytical	 center	 of	 Cairo	 University,	 Giza,	 Egypt.	
Benzofuroxans	(1a,b)	were	prepared	according	to	a	procedure	
reported	previously	[21].	
	
2.1.	Synthesis	of	2‐(arylcarbamoyl)‐1‐hydroxy‐5‐methyl‐1H‐
benzo[d]imidazole‐3‐oxide	(3a‐d)	
	
A	 mixture	 of	 benzofuroxan	 (1a)	 (0.45	 g,	 3	 mmol)	 and	
cyanoacetanilide	 derivatives	 (2a)	 (0.523	 g,	 3	 mmol),	 (2b)	
(0.523	g,	3	mmol),	 (2c)	 (0.571	g,	3	mmol)	or	 (2d)	 (0.571	g,	3	
mmol)	was	stirred	 in	ethanol	 (30	mL)	with	piperidine	 (3	mL)	
overnight.	The	obtained	precipitates	were	filtered	off,	dried	and	
recrystallized	 from	 ethanol	 to	 afford	 the	 benzimidazole	
derivatives	(3a‐d).	
3a,	 Dirty	 yellow	 solid,	 M.p.:	 217	 oC.	 Yield:	 70%.	 IR	 (KBr,	
max,	 cm‐1):	 3430	 (OH),	 3250	 (NH),	 1660	 (C=O),	 1620	 (C=N),	
1236,	 1317	 (N→O).	 1H	 NMR	 (DMSO,	 δ	 ppm):	 2.0	 (s,	 1H,	 OH),	
2.12	(s,	3H,	CH3),	2.34	(s,	3H,	CH3),	7.06‐7.50	(m,	7H,	Ar‐H),	9.15	
(s,	 1H,	 NH).	 MS	 (m/z,	 %):	 296	 (M+‐1,	 26).	 Anal.	 Calcd.	 for	
C16H15N3O3	(297.31):	C,	64.64;	H,	5.09.	Found:	C	64.56;	H,	5.12.	
3b,	 Dirty	 yellow	 solid,	 M.p.:	 206	 oC.	 Yield:	 75%.	 IR	 (KBr,	
max,	 cm‐1):	 3452	 (OH),	 3226	 (NH),	 1691	 (C=O),	 1618	 (C=N),	
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1231,	 1323	 (N→O).	 1H	 NMR	 (DMSO,	 δ	 ppm):	 2.0	 (s,	 1H,	 OH),	
2.34	(s,	6H,	2CH3),	7.06‐7.56	(m,	7H,	Ar‐H),	9.15	(s,	1H,	NH).	MS	
(m/z,	%):	297	(M+,	60).	Anal.	Calcd.	for	C16H15N3O3	(297.31):	C,	
64.64;	H,	5.09;	N,	14.13.	Found:	C	64.41;	H,	4.97;	N,	14.37.	
3c,	 Yellowish	 red	 solid,	M.p.:	 196	 oC.	 Yield:	 60%.	 IR	 (KBr,	
max,	 cm‐1):	 3448	 (OH),	 3248	 (NH),	 1680	 (C=O),	 1632	 (C=N),	
1236,	 1335	 (N→O).	 1H	 NMR	 (DMSO,	 δ	 ppm):	 2.0	 (s,	 1H,	 OH),	
2.34	 (s,	 3H,	 CH3),	 3.83	 (s,	 3H,	OCH3),	 6.73‐7.50	 (m,	 7H,	Ar‐H),	
9.15	 (s,	 1H,	 NH).	 MS	 (m/z,	%):	 313	 (M+,	 33).	 Anal.	 Calcd.	 for	
C16H15N3O4	(313.31):	C,	61.34;	H,	4.83;	N,	13.41.	Found:	C	61.19;	
H,	4.86;	N,	13.56.	
3d,	Reddish	yellow	solid,	M.p.:	300	oC.	Yield:	77%.	IR	(KBr,	
max,	 cm‐1):	 3437	 (OH),	 3236	 (NH),	 1687	 (C=O),	 1627	 (C=N),	
1234,	1314	(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.34	(s,	3H,	CH3),	
3.83	(s,	3H,	OCH3),	7.07‐7.50	(m,	7H,	Ar‐H),	9.15	(br.,	s,	1H,	NH).	
MS	 (m/z,	 %):	 314	 (M++1,	 43).	 Anal.	 Calcd.	 for	 C16H15N3O4	
(313.31):	C,	61.34;	H,	4.83.	Found:	C	61.37;	H,	4.88.	
	
2.2.	Synthesis	of	1‐hydroxy‐1H‐benzo[d]imidazole‐3‐oxides	
(6a,	b)	
	
A	 mixture	 of	 benzofuroxan	 (1b)	 (0.45	 g,	 3	 mmol)	 and	
rhodanine	derivatives	(4a)	(0.67	g,	3	mmol)	or	(4b)	(0.718	g,	3	
mmol)	was	heated	under	reflux	for	6	hours	in	ethanol	(30	mL)	
in	 the	 presence	 of	 sodium	 ethoxide	 (0.069	 g,	 3	 mmol).	 The	
reaction	mixture	was	 left	 to	 stand	 at	 room	 temperature	 for	 3	
hours,	 then	 poured	 into	 crushed	 ice	 and	 acidified	with	 dilute	
HCl,	 effervescence	 with	 evolution	 of	 CO2	 was	 observed.	 The	
formed	 precipitate	 was	 filtered,	 dried	 and	 crystallized	 from	
ethanol	to	give	benzimidazole	derivatives	(6a,b).		
6a,	 Reddish	 brown	 crystals,	 M.p.:	 254	 oC.	 Yield:	 70%.	 IR	
(KBr,	 max,	 cm‐1):	 3250	 (NH),	 1248,	 1343	 (N→O).	 1H	 NMR	
(DMSO,	 δ	 ppm):	 2.0	 (s,	 1H,	 OH),	 2.2	 (s,	 3H,	 CH3),	 4.10	 (s,	 1H,	
NH),	 6.85‐8.56	 (m,	 8H,	 Ar‐H).	 MS	 (m/z,	%):	 239	 (M+‐16,	 15).	
Anal.	Calcd.	for	C14H13N3O2	(255.27):	C,	65.87;	H,	5.13.	Found:	C,	
65.53;	H,	5.32.	
6b,	 Reddish	 brown	 crystals,	 M.p.:	 160	 oC.	 Yield:	 60%.	 IR	
(KBr,	 max,	 cm‐1):	 3250	 (NH),	 1248,	 1343	 (N→O).	 1H	 NMR	
(DMSO,	δ	ppm):	2.0	 (s,	1H,	OH),	2.34	(s,	3H,	CH3),	3.83	 (s,	3H,	
OCH3),	4.10	(s,	1H,	NH),	6.18‐7.50	(m,	8H,	Ar‐H).	MS	(m/z,	%):	
272	(M++1,	16).	Anal.	Calcd.	 for	C14H13N3O3	(271.27):	C,	61.99;	
H,	4.83;	N,	15.49.	Found:	C,	61.74;	H,	5.11;	N,	15.56.	
	
2.3.	Synthesis	of	2,2'‐dithiano‐Δ5,5'‐bi‐4‐thiazolidinones	
(8a,b)	
	
A	 mixture	 of	 benzofuroxan	 (1b)	 (0.45	 g,	 3	 mmol),	
rhodanine	derivatives	(4a)	(0.67	g,	3	mmol)	or	(4b)	(0.718	g,	3	
mmol),	and	catalytic	amount	of	anhydrous	sodium	acetate	(0.5	
g,	6	mmol)	in	acetic	acid	(20	mL)	was	heated	on	water	bath	at	
90	 oC	 for	 2‐3	 hours.	 The	 reaction	 mixture	 was	 then	 filtered,	
dried	then	heated	with	hot	ethanol	filtered	while	hot	to	give	4‐
thiazolidinone	dimers	(8a,b).	
8a,	Dark	yellow	solid,	M.p.:	 >	300	 oC.	Yield:	82%.	 IR	 (KBr,	
max,	 cm‐1):	 3232	 (NH),	 1248,	 1343	 (N→O).	 1H	NMR	 (DMSO,	 δ	
ppm):	2.42	(s,	6H,	2CH3),	6.89‐7.59	(m,	8H,	Ar‐H).	MS	(m/z,	%):	
442	(M+,	75).	Anal.	Calcd.	for	C20H14N2O2S4	(442.60):	C,	54.27;	H,	
3.19;	N,	6.33;	S,	28.98.	Found:	C,	54.40;	H,	3.26;	N,	6.25;	S,	29.08.	
8b,	Reddish	brown	solid,	M.p.:	>300	oC.	Yield:	90%.	IR	(KBr,	
max,	 cm‐1):	 3250	 (NH),	 1236,	 1335	 (N→O).	 1H	NMR	 (DMSO,	 δ	
ppm):	 3.80	 (s,	 6H,	 2OCH3),	 6.91‐7.50	 (m,	 8H,	 Ar‐H).	MS	 (m/z,	
%):	 474	 (M+,	 12).	 Anal.	 Calcd.	 for	 C20H14N2O4S4	 (474.60):	 C,	
50.61;	H,	2.97.	Found:	C,	50.58;	H,	2.93.	
	
2.4.	Synthesis	of	3‐methyl‐E‐2‐(1‐(2‐(hydrazinecarbono	
thioyl)‐hydrazono)‐ethyl)‐	quinoxalin‐1,4‐dioxide	(12)	
	
To	a	boiling	solution	of	10a	(0.655	g,	3	mmol)	in	methanol	
(15	 mL)	 containing	 2	 drops	 of	 conc.	 HCl,	 was	 added	 a	
methanolic	 solution	 of	 thiocarbohydrazide	 (11)	 (0.318	 g,	 3	
mmol	 in	10	mL	methanol)	with	 stirring.	The	 reaction	mixture	
was	 refluxed	 for	 5	 hours	 and	 then	 allowed	 to	 stand	 at	 room	
temperature	overnight.	The	separated	product	was	filtered	off	
and	 recrystallized	 from	methanol	 to	 give	12.	 Yellow	 crystals,	
M.p.:	237	oC.	Yield:	72%.	IR	(KBr,	max,	cm‐1):	1250	(C=S),	1320	
(N→O),	1620	(C=N),	3220	(NH),	3410	(NH2).	1H	NMR	(DMSO,	δ	
ppm):	1.81	(s,	3H,	CH3),	2.01	(s,	2H,	NH2),	2.9	(s,	3H,	CH3),	8.2‐
8.6	 (m,	 4H,	 Ar‐H),	 8.68	 (br.	 s.,	 2H,	 2NH).	 MS	 (m/z,	 %):	 308	
(M++2,	43).	Anal.	 Calcd.	 for	C12H14N6O2S	 (306.34):	C,	 47.05;	H,	
4.61;	 N,	 27.43;	 S,	 10.47.	 Found:	 C,	 46.91;	 H,	 4.64;	 N,	 27.50;	 S	
10.55. 	
	
2.5.	Reaction	of	12	with	formic	acid:	Formation	of	3‐methyl‐
E‐2‐(1‐(2‐(1,3,4‐thiadiazol‐2‐yl)‐hydrazono)‐ethyl)‐
quinoxaline	1,4‐dioxide	(15)	
	
A	mixture	of	12	(1	g,	3	mmol)	and	formic	acid	(15	mL)	was	
heated	under	reflux	for	4	hours.	The	reaction	mixture	was	then	
allowed	 to	 stand	 overnight	 at	 room	 temperature.	 The	 excess	
formic	 acid	was	 evaporated	under	vacuo	 and	 the	 residue	was	
crystallized	from	ethanol	to	give	15.	Dark	yellow	crystals,	M.p.:	
80	oC.	Yield:	60%.	IR	(KBr,	max,	cm‐1):	3315	(NH),	1610	(C=N),	
1330	(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.91	(s,	3H,	CH3),	2.95	(s,	
3H,	CH3),	7.0	(s,	1H,	NH),	7.5	(s,	1H,	CH),	8.1‐8.6	(m,	4H,	Ar‐H).	
MS	 (m/z,	 %):	 316	 (M+,	 71).	 Anal.	 Calcd.	 for	 C13H12N6O2S	
(316.34):	C,	49.36;	H,	3.82.	Found:	C,	49.39;	H,	3.87.	
	
2.6.	Synthesis	of	2,6‐dimethyl‐3‐(2‐hydroxy‐2‐oxoindolin‐3‐
yl)acetyl)‐	quinoxaline‐1,4‐dioxide	(16)	
	
To	a	mixture	of	isatin	(0.397	g,	2.7	mmol)	and	2,6‐dimethyl‐
3‐acetylquinoxaline‐1,4‐dioxide	 (10b)	 (0.627	 g,	 2.7	 mmol)	 in	
absolute	 ethanol	 (15	 mL),	 5	 drops	 of	 piperidine	 were	 added	
and	 the	 reaction	 mixture	 was	 allowed	 to	 stand	 overnight	 at	
room	temperature.	The	separated	crystals	was	filtered	off	and	
crystallized	from	ethanol	to	give	16.	Dark	yellow	powder,	M.p.:	
>300	 oC.	 Yield:	 90%.	 IR	 (KBr,	 max,	 cm‐1):	 1335	 (N→O),	 1700	
(cyclic	imide),	3447	(OH).	1H	NMR	(DMSO,	δ	ppm):	2.33	(s,	3H,	
CH3),	2.91	(s,	3H,	CH3),	3.65	(s,	1H,	OH),	4.13	(s,	2H,	CH2),	6.85‐
7.72	(m,	7H,	Ar‐H),	8.2	(s,	1H,	NH).	MS	(m/z,	%):	379	(M+,	14).	
Anal.	Calcd.	for	C20H17N3O5	(379.37):	C,	63.32;	H,	4.52;	N,	11.08.	
Found:	C,	63.25;	H,	4.47;	N,	11.00.	
	
2.7.	Synthesis	of	(E)‐2,6‐dimethyl‐3‐(2‐oxoindolin‐3‐
ylidene)acetyl)‐quinoxalin‐1,4‐dioxide	(17)	
	
A	mixture	containing	16	(1.897	g,	5	mmol),	(0.5	mL)	conc.	
HCl,	 and	 glacial	 acetic	 acid	 (20	mL)	was	 refluxed	 for	 2	 hours	
and	 then	 left	 to	 stand	 at	 room	 temperature	 overnight,	 fine	
needles	were	 formed.	 The	 formed	 precipitate	was	 filtered	 off	
and	recrystallized	from	acetic	acid	to	give	17.	Brownish	yellow	
powder,	 M.p.:	 265	 oC.	 Yield:	 65%.	 IR	 (KBr,	 max,	 cm‐1):	 1725	
(α,β‐unsaturated	 ketone),	 1330	 (N→O).	 1H	 NMR	 (DMSO,	 δ	
ppm):	2.34	(s,	3H,	CH3),	2.91	(s,	3H,	CH3),	6.97‐8.74	(m,	7H,	Ar‐
H),	7.32	 (s,	1H,	CH),	8.2	 (s,	1H,	NH).	MS	(m/z,	%):	362	(M++1,	
35).	Anal.	 Calcd.	 for	C20H15N3O4	 (361.35):	C,	 66.48;	H,	4.18;	N,	
11.63.	Found:	C,	66.40;	H,	4.13;	N,	11.70.	
	
2.8.	Synthesis	of	3‐cinnamoyl‐2,6‐dimethyl‐quinoxalin‐1,4‐
dioxides	(18)	
	
A	 mixture	 of	 2‐methyl‐3‐acetyl‐quinoxalin‐1,4‐dioxide	
(10a)	(0.655	g,	3	mmol)	and	benzaldehyde	(0.318	g,	3	mmol)	in	
methanolic	sodium	hydroxide	(10	mL,	5%)	was	stirred	for	5‐10	
minutes	 at	 room	 temperature.	 The	 formed	 yellow	 to	 orange	
precipitate	was	filtered	off,	washed	with	water	and	crystallized	
from	the	appropriate	solvent	(acetic	acid)	to	give	the	cinnamoyl	
derivative	18.	Yellow	crystals,	M.p.:	197	oC.	Yield:	80%.	IR	(KBr,	
max,	 cm‐1):	 1725	 (C=O),	 1590	 (C=C),	 1242,	 1325	 (N→O).	 1H	
NMR	(DMSO,	δ	ppm):	2.31	(s,	3H,	CH3),	2.9	(s,	3H,	CH3),	6.7	(d,	
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1H,	 CH),	 7.7	 (d,	 1H,	 CH),	 7.2‐7.8	 (m,	 8H,	 Ar‐H).	MS	 (m/z,	%):	
321	(M++1,	23).	Anal.	Calcd.	 for	C19H16N2O3	(320.34):	C,	71.24;	
H,	5.03.	Found:	C,	71.19;	H,	5.00.	
	
2.9.	Synthesis	of	2,6‐dimethyl‐3‐(5‐phenyl‐4,5‐dihydro‐1H‐
pyrazole‐3‐yl)quinoxalin‐1,4‐dioxide	(19)	
	
To	a	solution	of	18	 (0.961	g,	3	mmol)	 in	ethanol	 (15	mL),	
hydrazine	hydrate	 (98%,	0.0751	g,	1.5	mmol)	was	added.	The	
reaction	mixture	was	refluxed	for	3	hours	and	left	to	cool.	The	
crystalline	 precipitate	 was	 filtered	 off,	 dried	 and	 crystallized	
from	ethanol	to	give	19.	Yellowish	crystals,	M.p.:	184	oC.	Yield:	
70%.	IR	(KBr,	max,	cm‐1):	3250	(NH),	1620	(C=N),	1320	(N→O).	
1H	NMR	(DMSO,	δ	ppm):	2.3	 (s,	3H,	CH3),	2.9	 (s,	3H,	CH3),	3.9	
(dd,	 J=1.90	 Hz,	 1H,	 CH),	 [3.19	 (dd,	 J=1.85	 Hz,	 1H),	 3.44	 (dd,	
J=1.85	Hz,	1H)	CH2],	7.06‐7.72	(m,	8H,	Ar‐H),	8.3	(s,	1H,	NH).	MS	
(m/z,	%):	333	(M+‐1,	63).	Anal.	Calcd.	for	C19H18N4O2	(334.37):	
C,	68.25;	H,	5.43.	Found:	C,	68.00;	H,	5.20.	
	
2.10.	The	reaction	of	18	with	phenyl	hydrazine:	Synthesis	of	
2,6‐dimethyl‐3‐(1,5‐diphenyl‐4,5‐dihydro‐1H‐pyrazol‐3‐yl)‐
quinoxaline‐1,4‐dioxide	(20)	
	
Compound	18	 (0.961	 g,	 3	mmol)	 was	 boiled	with	 phenyl	
hydrazine	 (0.162	 g,	 1.5	 mmol)	 in	 acetic	 acid	 (10	 mL)	 for	 3	
hours.	 The	 reaction	mixture	was	 left	 to	 cool	 and	 poured	 into	
crushed	 ice.	 The	 formed	 precipitate	 was	 filtered,	 dried	 and	
crystallized	 from	 ethanol	 to	 give	 20.	 Lemon	 yellow	 crystals,	
M.p.:	105	oC.	Yield:	67%.	IR	(KBr,	max,	cm‐1):	1620	(C=N),	1320	
(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.34	(s,	3H,	CH3),	2.91	(s,	3H,	
CH3),	3.90	(dd,	J=1.95	Hz,	1H,	CH),	3.20	(dd,	J=1.88	Hz,	1H),	3.40	
(dd,	 J=1.88	Hz,	1H)	CH2,	7.2‐7.5	 (m,	13H,	Ar‐H).	MS	 (m/z,	%):	
410	(M+,	62).	Anal.	Calcd.	for	C25H22N4O2	(410.47):	C,	73.15;	H,	
5.40;	N,	13.65.	Found:	C,	73.00;	H,	5.11;	N,	13.58.	
	
2.11.	The	reaction	of	18	with	hydroxylamine	hydrochloride:	
Synthesis	of	2,6‐dimethyl‐3‐(5‐phenyl‐4,5‐dihydroisoxazol‐3‐
yl)‐quinoxaline‐1,4‐dioxide	(21)	
	
A	 mixture	 of	 18	 (0.961	 g,	 3	 mmol),	 hydroxylamine	
hydrochloride	(0.104	g,	1.5	mmol),	sodium	hydroxide	(0.1	g,	2.5	
mmol)	 and	 ethanol	 (15	 mL)	 was	 refluxed	 for	 4	 hours.	 After	
cooling,	the	separated	material	was	filtered	off	and	crystallized	
from	 ethanol	 to	 give	 21.	 Light	 yellow	 crystals,	 M.p.:	 102	 oC.	
Yield:	 72%.	 IR	 (KBr,	max,	 cm‐1):	 1626	 (C=N),	 1340	 (N→O).	 1H	
NMR	(DMSO,	δ	ppm):	2.34	(s,	3H,	CH3),	2.91	(s,	3H,	CH3),	[3.13	
(dd,	 J=2.03	 Hz,	 1H),	 3.39	 (dd,	 J=2.03	 Hz,	 1H)	 CH2],	 5.96	 (dd,	
J=2.09	Hz,	1H,	CH),	7.06‐7.70	(m,	8H,	Ar‐H).	MS	(m/z,	%):	335	
(M+,	18).	Anal.	Calcd.	for	C19H17N3O3	(335.36):	C,	68.05;	H,	5.11;	
N,	12.53.	Found:	C,	68.30;	H,	5.36;	N,	12.65.	
	
2.12.	Synthesis	of	2,6‐dimethyl‐3‐(2‐pyridinyl‐4,6‐
diphenyl)quinoxalin‐1,4‐dioxide	(24)	
	
To	a	solution	of	phenacyl	pyridinium	bromide	(22)	(0.834	
g,	 3	mmol)	 and	ammonium	acetate	 (2	 g)	 in	 glacial	 acetic	 acid	
(10	mL)	a	solution	of	18	(0.961	g,	3	mmol)	in	glacial	acetic	acid	
(10	 mL)	 was	 added	 gradually	 with	 continuous	 stirring.	 The	
reaction	mixture	was	refluxed	for	2	h	and	then	left	to	cool	and	
poured	 into	 crushed	 ice.	 The	 formed	 precipitate	 was	 filtered	
off,	 dried	 and	 crystallized	 from	 methanol	 to	 afford	 24.	
Yellowish	 brown	 crystals,	 M.p.:	 186	 oC.	 Yield:	 80%.	 IR	 (KBr,	
max,	 cm‐1):	 3000‐3077	 (CH	 streching),	 1620	 (C=N),	 1330	
(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.35	(s,	3H,	CH3),	2.93	(s,	3H,	
CH3),	8.11	and	8.56	(2s,	2H,	Py	H`s),	7.06‐8.30	(m,	13H,	Ar‐H).	
MS	 (m/z,	 %):	 419	 (M+,	 30).	 Anal.	 Calcd.	 for	 C27H21N3O2	
(419.47):	C,	77.31;	H,	5.05.	Found:	C,	77.09;	H,	4.89.	
	
2.13.	Synthesis	of	3‐(6‐amino‐5‐cyano‐4‐phenylpyridine‐2‐
yl)‐2,6‐dimethyl‐quinoxalin‐1,4‐dioxide	(25)	
	
A	mixture	of	18	(0.961	g,	3	mmol),	malononitrile	(0.198	g,	3	
mmol)	and	ammonium	acetate	(0.164	g,	2	mmol)	was	heated	at	
150	oC	for	4	hours.	The	solid	material	was	washed	with	water	
and	 recrystallized	 from	 benzene	 to	 give	 25.	 Coffee	 Brown	
crystals,	 M.p.:	 100	 oC.	 Yield:	 70%.	 IR	 (KBr,	 max,	 cm‐1):	 3470	
(NH2),	2220	(CN),	1640	(C=N),	1320	(N→O).	1H	NMR	(DMSO,	δ	
ppm):	2.30	(s,	3H,	CH3),	2.90	(s,	3H,	CH3),	7.05‐7.70	(m,	8H,	Ar‐
H),	7.60	(s,	2H,	NH2),	8.2	(s,	1H,	py‐H).	MS	(m/z,	%):	383	(M+,	
90).	Anal.	 Calcd.	 for	C22H17N5O2	 (383.40):	C,	 68.92;	H,	4.47;	N,	
18.27.	Found:	C,	69.03;	H,	4.53;	N,	18.45.	
	
2.14.	Synthesis	of	2,6‐dimethyl‐3‐(hydrazinecarbonyl)‐
quinoxalin‐1,4‐dioxide	(26)	
	
A	 mixture	 of	 2,6‐dimethyl‐3‐carboethoxyquinoxalin‐1,4‐
dioxide	(10c)	(0.787	g,	3	mmol)	and	hydrazine	hydrate	(80%,	3	
mL)	in	absolute	ethanol	(20	mL)	was	refluxed	for	6	hours	and	
left	 to	 stand	 overnight	 at	 room	 temperature.	 The	 separated	
crystals	were	filtered	off,	dried	and	crystallized	from	ethanol	to	
give	26.	Yellow	crystals,	M.p.:	218	oC.	Yield:	70%.	IR	(KBr,	max,	
cm‐1):	 3380	 (NH2),	 3350	 (NH),	 1650	 (C=O),	 1330	 (N→O).	 1H	
NMR	(DMSO,	δ	ppm):	2.00	(s,	2H,	NH2),	2.30	(s,	3H,	CH3),	2.91	
(s,	3H,	CH3),	7.06	(s,	1H,	Ar‐H),	7.23	(d,	1H,	Ar‐H),	7.70	(d,	1H,	
Ar‐H),	8.00	(s,	1H,	NH).	Anal.	Calcd.	for	C11H12N4O3	(248.24):	C,	
53.22;	H,	4.87;	N,	22.57.	Found:	C,	53.07;	H,	4.91;	N,	22.64.	
	
2.15.	Synthesis	of	2,6‐dimethyl‐3‐(5‐thioxo‐1',3',4'‐
oxadiazolo‐2'‐yl)‐quinoxalin‐1,4‐dioxide	(27)	
	
A	 mixture	 of	 26	 (1.201	 g,	 5	 mmol)	 in	 ethanol	 (10	 mL),	
potassium	 hydroxide	 (0.281	 g,	 5	mmol)	 in	 water	 (3	mL)	 and	
carbon	disulfide	(0.381	g,	5	mmol)	was	heated	under	reflux	for	
7	 hours	 or	 until	 the	 evolution	 of	 H2S	 ceased.	 The	 reaction	
mixture	was	left	 to	cool,	poured	into	crushed	ice	and	acidified	
with	 conc.	 HCl.	 The	 precipitate	 was	 filtered	 off,	 washed	 with	
water,	dried	and	crystallized	from	ethanol	to	give	27.	Brownish	
crystals,	 M.p.:	 210	 oC.	 Yield:	 85%.	 IR	 (KBr,	 max,	 cm‐1):	 1595	
(C=N),	 1330	 (N→O),	 1300‐1100	 (C=S),	 2600‐2620	 (SH).	 1H	
NMR	(DMSO,	δ	ppm):	2.34	(s,	3H,	CH3),	2.90	(s,	3H,	CH3),	7.00	
(s,	1H,	NH),	7.06	(s,	1H,	Ar‐H),	7.23	(d,	1H,	Ar‐H),	7.70	(d,	1H,	
Ar‐H).	MS	(m/z,	%):	290	(M+,	33).	Anal.	Calcd.	for	C12H10N4O3S	
(290.30):	C,	49.65;	H,	3.47.	Found:	C,	49.77;	H,	3.54.	
	
2.16.	Synthesis	of	3,7‐dimethyl‐1,4‐dioxyquinoxaline‐2‐
carboxylic	acid	N`‐(3,7‐dimethyl‐1,4‐dioxyquinoaline‐2‐
carbonyl)hydrazide	derivative	(29)	
	
A	mixture	of	26	(0.721	g,	3	mmol),	acetoacetanilide	(0.532	
g,	3	mmol)	 in	glacial	acetic	acid	(15	mL)	was	refluxed	 for	3	h.	
After	 cooling,	 the	 precipitate	 was	 filtered	 off,	 dried	 and	
recrystallized	from	acetic	acid	to	give	29.	Dark	yellow	powder,	
M.p.:	 >300	 oC.	 Yield:	 60%.	 IR	 (KBr,	 max,	 cm‐1):	 3250,	 3280	
(NH/NH),	 1700	 (two	 C=O),	 1327	 (N→O).	 1H	 NMR	 (DMSO,	 δ	
ppm):	2.55	(s,	6H,	2CH3),	2.91	(s,	6H,	2CH3),	6.80‐7.60	(m,	6H,	
Ar‐H),	9.50	(br.	s.,	2H,	NH/NH).	MS	(m/z,	%):	432	(M+‐32,	20).	
Anal.	Calcd.	for	C22H20N6O6	(464.43):	C,	56.89;	H,	4.34;	N,	18.10.	
Found:	C,	56.97;	H,	4.42;	N,	18.36.	
	
2.17.	Synthesis	of	3‐(3‐carboxamido‐2,6‐dimethyl‐1‐
phenylquinoxalin‐1,4‐dioxide)thiourea	(30)	
	
Phenylisothiocyanate	 (0.406	 g,	 3	 mmol)	 was	 added	 to	 a	
solution	 of	26	 (0.721	 g,	 3	mmol)	 in	 ethanol	 (20	mL)	 and	 the	
reaction	mixture	was	heated	for	4	hours	on	water	bath	then	left	
to	 cool.	 The	 precipitated	 solid	 product	 was	 filtered	 off	 and	
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crystallized	from	ethanol	to	give	30.	Orange	crystals,	M.p.:	192	
oC.	Yield:	88%.	IR	(KBr,	max,	cm‐1):	3250,	3300,	3350	(NH/NH),	
1220	(C=S),	1350	(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.00	(s,	1H,	
NH),	2.34	(s,	3H,	CH3),	2.90	(s,	3H,	CH3),	4.20	(s,	1H,	NH),	6.80‐
7.70	 (m,	8H,	Ar‐H),	9.35	 (s,	1H,	NH),	9.55	 (s,	2H,	NH/NH).	MS	
(m/z,	%):	383	(M+,	80).	Anal.	Calcd.	for	C18H17N5O3S	(383.42):	C,	
56.38;	H,	4.47;	N,	18.27.	Found:	C,	56.32;	H,	4.41;	N,	18.38.	
		
2.18.	Synthesis	of	3‐(2,6‐dimethylquinoxalin‐1,4‐dioxide)‐5‐
mercapto‐4‐phenyl‐4H‐1,2,4‐triazole	(31)	
	
A	solution	of	30	 (1.15	g,	3	mmol)	 in	potassium	hydroxide	
(10%,	20	mL)	was	 refluxed	 for	8	hours.	The	 reaction	mixture	
was	kept	to	stand	overnight	at	room	temperature,	then	poured	
into	crushed	ice	and	acidified	with	dilute	acetic	acid.	The	solid	
product	 was	 filtered	 off,	 washed	 with	 water,	 dried	 and	
crystallized	from	ethanol	to	give	31.	Orange	powder,	M.p.:	248	
oC.	 Yield:	 70%.	 IR	 (KBr,	 max,	 cm‐1):	 2600‐2550	 (SH),	 1600	
(C=N),	1337	(N→O),	1300‐1100	(C=S).	1H	NMR	(DMSO,	δ	ppm):	
2.35	(s,	3H,	CH3),	2.91	 (s,	3H,	CH3),	3.42	 (s,	1H,	SH),	7.05‐7.55	
(m,	8H,	Ar‐H).	MS	(m/z,	%):	365	(M+,	5),	366	(M++1,	10).	Anal.	
Calcd.	 for	C18H15N5O2S	 (365.41):	C,	59.16;	H,	4.14;	N,	19.17;	 S,	
8.78.	Found:	C,	59.32;	H,	4.27;	N,	19.10;	S,	8.85.	
	
2.19.	Synthesis	of	3‐(2,6‐dimethylquinoxalin‐1,4‐dioxide)‐2‐
phenylimino‐4‐thiazolidinone	(32)	
	
To	 a	 solution	of	30	 (1.15	 g,	 3	mmol)	 in	 glacial	 acetic	 acid	
(20	mL)	was	 added	monochloroacetic	 acid	 (0.284	 g,	 3	mmol)	
and	 anhydrous	 sodium	 acetate	 (0.3	 g).	 The	 reaction	 mixture	
was	refluxed	for	8	hours,	then	left	to	cool	at	room	temperature	
and	 then	 poured	 into	 crushed	 ice.	 The	 separated	 solid	 was	
filtered	 off,	 washed	 thoroughly	 with	 water,	 dried	 and	
crystallized	from	ethanol	to	give	32.	Light	yellow	crystals,	M.p.:	
86	oC.	Yield:	60%.	 IR	(KBr,	max,	cm‐1):	3250	(NH),	1680,	1600	
(C=O),	1535	(C=N),	1335	(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.34	
(s,	3H,	CH3),	2.90	 (s,	3H,	CH3),	4.10	 (s,	2H,	CH2),	7.06‐7.70	(m,	
8H,	 Ar‐H).	 MS	 (m/z,	 %):	 423	 (M+,	 20).	 Anal.	 Calcd.	 for	
C20H17N5O4S	 (423.45):	 C,	 56.73;	 H,	 4.05;	 N,	 16.54;	 S,	 7.57.	
Found:	C,	56.68;	H,	4.08;	N,	16.45;	S,	7.60.	
	
2.20.	Synthesis	of	3‐carbazido‐2,6‐dimethylquinoxalin‐1,4‐
dioxide	(33)	
	
To	a	suspension	of	26	(0.721	g,	3	mmol)	in	dioxane	(10	mL)	
and	acetic	acid	(10	mL),	sodium	nitrite	(0.5	g)	in	water	(1.3	mL)	
was	 added	with	 stirring	 at	 0‐2	 oC.	 Stirring	was	 continued	 for	
further	 30	 minutes	 after	 complete	 addition	 of	 sodium	 nitrite	
solution.	The	separated	material	was	 filtered	off,	washed	with	
water	 and	 crystallized	 from	 acetic	 acid	 to	 give	 33.	 Yellow	
crystals,	 M.p.:	 78	 oC.	 Yield:	 55%.	 IR	 (KBr,	 max,	 cm‐1):	 2157	
(strong	N3),	1691	(CO),	1341	(N→O).	1H	NMR	(DMSO,	δ	ppm):	
2.35	(s,	3H,	CH3),	2.93	(s,	3H,	CH3),	7.08	(s,	1H,	Ar‐H),	7.21	(d,	
J=7.5	Hz,	1H,	Ar‐H),	7.65	(d,	J=7.5	Hz,	1H,	Ar‐H).	MS	(m/z,	%):	
259	 (M+,	35).	Anal.	 Calcd.	 for	C11H9N5O3	 (259.22):	C,	50.97;	H,	
3.50;	N,	27.02.	Found:	C,	51.02;	H,	3.56;	N,	27.17.	
	
2.21.	Synthesis	of	2,6‐dimethyl‐3‐ethoxycarbonylamino	
quinoxalin‐1,4‐dioxide	(34)	
	
	The	 azide	 33	 (0.778	 g,	 3	 mmol)	 in	 absolute	 ethanol	 (30	
mL)	 was	 refluxed	 for	 5	 hours	 and	 the	 reaction	 mixture	 was	
filtered	while	hot	to	remove	any	insoluble	material.	The	filtrate	
was	 evaporated	 and	 the	 residue	 crystallized	 from	 ethanol	 to	
give	34.	Yellow	crystals,	M.p.:	200	oC.	Yield:	72%.	IR	(KBr,	max,	
cm‐1):	 3382	 (NH),	 1723	 (CO,	 ester),	 1339	 (N→O).	 1H	 NMR	
(DMSO,	δ	ppm):	1.80	(t,	 J=13.7	Hz,	3H,	CH3),	2.30	(s,	3H,	CH3),	
2.90	(s,	3H,	CH3),	3.50	(q,	J=13.7	Hz,	2H,	CH2),	6.70‐7.30	(m,	3H,	
Ar‐H),	8.00	(s,	1H,	NH).	MS	(m/z,	%):	277	(M+,	13).	Anal.	Calcd.	
for	C13H15N3O4	 (277.28):	C,	 56.31;	H,	5.45;	N,	15.15.	 Found:	C,	
56.43;	H,	5.57;	N,	15.27.	
	
2.22.	Synthesis	of	2,6‐dimethyl‐3‐isocyanatoquinoxalin‐1,4‐
dioxide	(35)	
	
The	azide	33	(0.778	g,	3	mmol)	in	dry	toluene	(20	mL)	was	
refluxed	for	3	hours.	After	cooling,	the	separated	material	was	
filtered	 off,	 dried	 and	 crystallized	 from	 benzene	 to	 give	 35.	
Reddish	crystals,	M.p.:	244	oC.	Yield:	66%.	IR	(KBr,	max,	cm‐1):	
1700	(C=O),	1330	(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.38	(s,	3H,	
CH3),	 2.91	 (s,	 3H,	 CH3),	 7.30	 (d,	 J=8.30	 Hz,	 1H,	 H7),	 7.70	 (d,	
J=8.30	Hz,	1H,	H8),	 7.06	 (s,	 1H,	H5).	MS	 (m/z,	%):	230	 (M+‐1,	
70).	 Anal.	 Calcd.	 for	 C11H9N3O3	 (231.21):	 C,	 57.14;	 H,	 3.92.	
Found:	C,	57.01;	H,	3.80.	
	
2.23.	Synthesis	of	3‐amino‐2,6‐dimethylquinoxalin‐1,4‐
dioxide	(36)	
	
The	 carbazide	33	 (0.778	 g,	 3	mmol)	 in	 acetic	 acid	 (5	mL)	
and	dioxane	(5	mL)	was	heated	for	30	minutes	and	then	left	to	
cool.	The	reaction	mixture	was	poured	into	water	(30	mL)	and	
then	extracted	with	ether	(three	times),	dried	over	anhydrous	
magnesium	sulfate;	the	solvent	was	evaporated	under	vacuo	to	
afford	36.	 Greyish	 crystals,	M.p.:	 202	 oC.	 Yield:	 70%.	 IR	 (KBr,	
max,	 cm‐1):	3480‐3440	 (NH2),	1350	 (N→O).	 1H	NMR	(DMSO,	δ	
ppm):	 2.34	 (s,	 3H,	 CH3),	 2.90	 (s,	 3H,	 CH3),	 6.90	 (s,	 2H,	 NH2),	
6.06‐7.70	 (m,	 3H,	 Ar‐H).	 MS	 (m/z,	 %):	 189	 (M+‐16,	 50),	 173	
(100).	 Anal.	 Calcd.	 for	 C10H11N3O2	 (205.21):	 C,	 58.53;	 H,	 5.40.	
Found:	C,	58.62;	H,	5.52.	
	
2.24.	Diazotization	and	coupling	of	40	with	β–naphthol:	
Synthesis	of	2,6‐dimethyl‐E‐3((2‐hydroxynaphthalen‐1‐
yl)diazenyl)‐quinoxalin‐1,4‐dioxide	(37)	
	
2,6‐Dimethyl‐3‐aminoquinoxalin‐1,4‐dioxide	(36)	(0.616	g,	
3	mmol)	was	dissolved	 in	 conc.	 hydrochloric	 acid	 (6	mL)	 and	
cooled	 to	 0	 oC	 in	 ice	 bath.	 Cold	 aqueous	 solution	 of	 sodium	
nitrite	(0.3	g	in	5	mL	water)	was	added	in	small	portions	to	the	
above	 amine	 hydrochloride	 solution.	 To	 the	 resulting	 sodium	
salt	solution	was	added	a	cold	solution	of	β–naphthol	(0.433	g,	
3	mmol)	 in	 sodium	hydroxide	 (10%,	10	mL),	 the	precipitated	
solid	 material	 was	 filtered	 off,	 washed	 with	 water	 and	
crystallized	from	ethanol	to	give	37.	Orange	powder,	M.p.:	238	
oC.	 Yield:	 80%.	 IR	 (KBr,	 max,	 cm‐1):	 3500	 (OH),	 1618	 (C=N),	
1495	(N=N),	1345	(N→O).	1H	NMR	(DMSO,	δ	ppm):	2.30	(s,	3H,	
CH3),	2.96	(s,	3H,	CH3),	5.40	(s,	1H,	OH),	7.06‐8.07	(m,	9H,	Ar‐
H).	 MS	 (m/z,	 %):	 360	 (M+,	 27).	 Anal.	 Calcd.	 for	 C20H16N4O3	
(360.37):	C,	66.66;	H,	4.48;	N,	15.55.	Found:	C,	66.57;	H,	4.53;	N,	
15.68.	
	
3.	Results	and	discussion		
	 	
It	is	well	established	that	Benzofuroxan	derivatives	exist	at	
room	temperature	as	a	mixture	of	tautomers.	The	substituents	
in	 the	benzene	ring	could	occupy	 the	5‐	or	6‐position	and	 the	
proportion	 of	 both	 tautomers	 in	 the	 equilibrium	 depends	 on	
the	electronic	characteristics	of	the	substituents	[22].	
The	 reaction	 of	 benzofuroxan	 (BFO)	 1a	 with	 the	 cyano‐
acetanilides	2a‐d	 in	 the	 presence	 of	 piperidine	 as	 catalyst	 at	
room	 temperature	 afforded	 the	 2‐(arylcarbamoyl)‐1‐hydroxy‐
5‐methyl‐1H‐benzo[d]imidazol‐3‐oxide	 derivatives	 3a‐d,	
respectively;	(Scheme	2).	
	
Scheme	2	
Fadda	et	al.	/	European	Journal	of	Chemistry	2	(1)	(2011)	51‐57	 55	
 
 
 
A	 probable	 mechanism,	 in	 line	 with	 other	 carbanion	
reactions	of	BFO's	is	outlined	in	(Scheme	3).	
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Scheme	3	
	
The	structures	of	3a‐d	were	elucidated	from	their	spectral	
and	elemental	analysis.	Thus,	the	IR	spectra	of	3a‐d	reveal	the	
presence	 of	 OH	 and	 NH	 groups	 (3430	 and	 3250	 cm‐1),	
respectively,	amide	carbonyl	(1660	cm‐1),	C=N	(1620	cm‐1)	and	
(N→O)	 functions	 (1236,	1317	 cm‐1).	The	 1H	NMR	spectrum	of	
3d	shows	two	singlets	each	integrated	for	3H	at	δ	2.34	and	3.83	
attributable	 to	methyl	and	methoxy	protons,	 respectively,	and	
the	 aromatic	 protons	 appears	 at	 δ	 7.07‐7.50	 (m,	 7H,	 Ar‐H),	
while	the	NH	proton	appears	as	a	broad	singlet	at	δ	9.15	ppm.	
Moreover,	 rhodanines	 are	 important	 anticonvulsant	 [16],	
anti‐inflammatory	 [17],	 antitubercular	 [18],	 and	 antibacterial	
agents	 [19].	 So,	 compounds	 having	 a	 combination	 of	
benzofuroxan	with	rhodanine	moieties	are	expected	to	posses	
marked	 biological	 properties.	 Unexpectedly	 when	 1b	 was	
reacted	with	rhodanines	4a,b	as	active	methylene	compounds,	
in	 the	presence	of	 sodium	ethoxide,	1‐hydroxy‐2‐(arylamino)‐
1H‐benzo[d]imidazole‐3‐oxide	 6	 was	 obtained	 instead	 of	 the	
thioxospirobenzoimidazole‐thiazolidine‐1,3‐dioxide	5	 (Scheme	
4).	
	
 
	
Scheme	4	
	
The	IR,	1H	NMR	and	mass	spectra	of	6a,b	are	in	agreement	
with	their	proposed	structures	(Scheme	5).	
If	the	above	reaction	afforded	compound	5,	so,	it	would	not	
have	shown	bands	in	both	the	IR	and	1H	NMR	spectrum	for	NH	
group.	
On	 the	 other	 hand,	 we	 report	 here	 the	 reaction	 of	 BFO's	
with	 rhodanine	 in	 the	 presence	 of	 a	 weaker	 base,	 such	 as	
freshly	 fused	 sodium	 acetate	 and	 drops	 of	 acetic	 acid.	 This	
versatile	 synthesis	 has	 afforded	 novel	 compounds	 hitherto	
inaccessible	by	classical	synthetic	methods.	Thus,	surprisingly,	
the	 reaction	 of	 rhodanines	 4a,b	 with	 benzofuroxan	 1a,b	 and	
catalytic	amount	of	freshly	fused	sodium	acetate	does	not	give	
the	 expected	 spiro	 benzimidazolyl‐4‐thiazolidinone	 5,	 but	
resulted	 in	 the	 formation	 of	 2,2'‐dithiano‐Δ5,5'‐bi‐4‐thiazo	
lidinones	7a,b	which	are	auto‐oxidized	to	2,2'‐dithiano‐Δ5,5'‐bi‐
4‐thiazolidinones	 8a,b,	 in	 which	 the	 benzofuroxan	 acts	 as	
oxidizing	 agent	 and	 in	 the	 same	 time	 it	 was	 reduced	 to																
o‐quinone	 dioxime	 9.	 The	 oxidizing	 capacity	 [21]	 of	
benzofuroxan	and	its	ability	to	oxidize	rhodanine	to	the	dimer	
derivatives	8a,b	via	 the	 formation	of	7	based	on	 initial	one	or	
two	 electron	 oxidation	 and	 the	 subsequent	 formation	 of	 o‐
quinone	 dioximes	 9a,b	 as	 side	 products	 are	 illustrated	 in	
(Scheme	 6).	 The	 structures	 were	 assigned	 to	 the	 bi‐
thiazolidinones	 class	 on	 the	 basis	 of	 the	 chemical	 shift	 of	 the	
methyl	groups	and	aromatic	rings	in	the	1H	NMR	spectra.	
	
 
	
Scheme	5	
	
 
	
Scheme	6	
	
In	addition,	thiocarbohydrazide	has	been	reported	to	show	
tubercular	activities	[30],	 in	vitro	and	high	insecticidal	activity	
towards	the	house‐fly	 in	comparison	with	DDT	[31].	Thus,	 the	
quinoxaline	N‐dioxide	10a	 reacts	with	 the	 thiocarbohydrazide	
11	 to	 afford	 the	 condensation	 product	 12	 which	 reacts	 with	
excess	formic	acid	to	give	3‐methyl‐E‐2‐(1‐(2‐(1,3,4‐thiadiazol‐
2‐yl)hydrazono)ethyl)‐quinoxaline‐1,4‐dioxide	 15	 presumably	
via	 the	 intermediates	 13	 and	 14.	 Here,	 formic	 acid	 was	
expected	 to	 reduce	 the	 C=N	 to	 the	 corresponding	 secondary	
amine,	however,	 formylation	of	NH2	group	 took	place	and	 the	
intermediate	 14	 was	 formed,	 which	 then	 loses	 a	 water	
molecule	to	give	15.	All	attempts	to	isolate	the	intermediate	14	
failed	(Scheme	7).	
Structures	 12	 and	 15	 were	 established	 on	 the	 basis	 of	
analytical	and	spectral	data	(see	experimental	part).		
On	 the	 other	 hand,	 it	 has	 been	 found	 that	 the	 reaction	 of	
isatin	with	quinoxaline	derivatives	10b	[29],	in	the	presence	of	
piperidine,	 afforded	 3‐(2‐hydroxy‐2‐oxoindolin‐3‐yl)acetyl)‐
2,6‐dimethyl‐quinoxalin‐1,4‐dioxide	 16,	 in	 quantitative	 yield	
(Scheme	 8).	 The	 structure	 of	16	 was	 established	 from	micro	
analytical	data	 as	well	 as	 the	 IR	 spectrum	which	 showed	well	
defined	 bands	 in	 the	 region	 3447	 cm‐1	 (OH)	 and	 1700	 cm‐1	
(cyclic	 imide).	 Dehydration	 of	 16	 by	 dilute	 alcoholic	 hydro‐
chloric	 acid	 or	 by	 hydrochloric	 acid	 in	 the	 presence	 of	 acetic	
acid	 gave	 (E)‐2,6‐dimethyl‐3‐(2‐oxoindolin‐3‐ylidene)acetyl)	
quinoxaline‐1,4‐dioxide	 17	 in	 good	 yield.	 IR	 spectrum	 of	 17	
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showed	 a	 characteristic	 band	 at	 1725‐1703	 cm‐1	 (α,β‐
unsaturated	ketone).		
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Scheme	7	
	
 
	
Scheme	8	
	
α,β‐Unsaturated	 ketones	 provide	 a	 valuable	 intermediate	
for	 building	 up	 various	 heterocycles.	 Thus,	 condensation	 of	
hydrazine	hydrate	 or	 phenyl	 hydrazine	with	3‐cinnamoyl‐2,6‐
dimethylquinoxaline‐1,4‐dioxide	18	 in	 boiling	 ethanol	 yielded	
the	yellow	pyrazoline	derivative,	2,6‐dimethyl‐3‐(5‐phenyl‐4,5‐
dihydro‐1H‐pyrazol‐3‐yl)quinoxaline‐1,4‐dioxide	19	and	 its	N‐
phenyl	isomer	20,	respectively.		
The	 formation	 of	 an	 isoxazoline	 ring	 could	 be	 effected	 by	
the	 reaction	 of	 18	 with	 hydroxylamine.	 Thus,	 when	 18	 was	
boiled	with	 hydroxylamine	 hydrochloride	 in	 alcoholic	 sodium	
hydroxide	 solution,	 the	 corresponding	 isoxazoline;	 3‐(3‐
quinoxaliolyl‐2,6‐dimethyl‐1,4‐dioxide)‐5‐phenyl‐4,5‐dihydro‐
1H‐isoxazoline	21	was	obtained	(Scheme	9).	
	
 
	
Scheme	9	
	
Krohnke	 [30]	 and	 Madhar	 [31]	 studied	 the	 reactivity	 of	
pyridinium	 ylides;	 however	 their	 synthetic	 applications	
remained	 unexplored.	 With	 a	 view	 to	 explore	 the	 synthetic	
potentiality	of	 this	reaction	we	report	here	the	synthesis	of	3‐
pyridyl‐2,6‐dimethylquinoxaline‐1,4‐dioxide	 24	 via	 the	
cyclization	 reaction	of	 the	α,β–unsaturated	ketone	18	with	N‐
phenacyl	pyridinium	bromide	22	in	acetic	acid	in	the	presence	
of	ammonium	acetate	as	the	cyclization	agent.	
The	reaction	presumably	proceeds	via	the	 intermediary	of	
ylide	 carbanion	 which	 is	 generated	 from	 pyridinium	 salt	
(Scheme	 10).	 This	 undergoes	 Michael	 type	 addition	 to	 α,β–
unsaturated	 carbonyl	 systems	 to	 yield	 1,5‐dicarbonyl	
pyridinium	 derivative	 23	 as	 intermediate	 which	 on	 reaction	
with	ammonium	acetate	gave	24.		
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Scheme	10	
	
The	condensation	of	18	with	malononitrile	in	the	presence	
of	 ammonium	 acetate	 gave	 3‐(6‐amino‐5‐cyano‐4‐phenyl	
pyridine‐2‐yl)‐2,6‐dimethylquinoxaline‐1,4‐dioxide	 25.	 Struc‐
tures	24	 and	25	 were	 supported	 by	 1H	NMR	 and	 IR	 spectral	
data	(see	experimental	part).	
When	 2,6‐dimethyl‐3‐carbethoxyquinoxalin‐1,4‐dioxide	
10c	was	 allowed	 to	 react	with	hydrazine	hydrate	 (80%),	 2,6‐
dimethyl‐3‐(hydrazinecarbonyl)‐quinoxalin‐1,4‐dioxide	 26	
was	obtained.	Treatment	of	26	with	potassium	hydroxide	and	
carbon	 disulphide	 gave	 2,6‐dimethyl‐3‐(5‐thioxo‐4,5‐dihydro‐
1',3',4'‐oxadiazol‐2'‐yl)quinoxalin‐1,4‐dioxide	27.	
Unexpectedly,	 when	 the	 hydrazide	 26	 was	 heated	 with	
acetoacetanilide	in	the	presence	of	acetic	acid,	the	product	was	
not	 the	 expected	 3‐pyrazole‐1‐carbonylquinoxaline	 derivative	
28	but	the	3,7‐dimethyl‐1,4‐dioxyquinoxaline‐2‐carboxylic	acid	
N`‐(3,7‐dimethyl‐1,4‐dioxyquinoaline‐2‐carbonyl)hydrazide	
derivative	29	was	obtained	(Scheme	11).	
On	 refluxing	 the	 hydrazide	 26	 in	 dry	 ethanol	 with	
phenylisothiocyanate,	 the	 1‐phenyl‐3‐(2,6‐dimethyl‐3‐carbox	
amido‐quinoxalin‐1,4‐dioxide)thiourea	 30	 was	 separated	 out.	
Heating	 the	 thiourea	 derivative	 30	 under	 reflux	 with	
chloroacetic	acid	and	sodium	acetate	in	acetic	acid	produced	3‐
(2,6‐dimethylquinoxalin‐1,4‐dioxide)‐2‐phenylimino‐4‐thia‐
zolidinone	32	in	good	yield	(Scheme	12).	
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Scheme	12	
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The	 IR,	 1H	 NMR	 and	 mass	 spectra	 of	 26‐32	 are	 in	
agreement	 with	 the	 proposed	 structures	 as	 shown	 in	 the	
experimental	part.	
2,6‐Dimethyl‐3‐carbohydrazidoquinoxalin‐1,4‐dioxide	 26	
on	 treatment	 with	 HNO2	 gave	 2,6‐dimethyl‐3‐carbazidoquin	
oxalin‐1,4‐dioxide	33	which	on	 refluxing	with	 ethanol	 for	 5	h	
produced	2,6‐dimethyl‐3‐ethoxycarbonylamino	quinoxalin‐1,4‐
dioxide	34	in	good	yield.	The	IR	spectra	of	compounds	33	and	
34	were	in	agreement	with	assigned	structures.	
The	decomposition	of	azides	 to	 isocyanate	and	nitrogen	 is	
known	 as	 the	 Curtius	 rearrangement.	 The	 reaction	 is	 a	
preparative	 method	 for	 isocyanate	 and	 compounds	 derivable	
from	isocyanates,	such	as	urethans,	ureas,	amides,	and	amines.	
When	 coupled	 with	 a	 hydrolytic	 step,	 the	 Curtius	
rearrangement	 becomes	 a	 particular	 procedure	 for	 replacing	
the	 azide	 group	 by	 an	 amino	 group.	 Thus	 azides	 undergo	
rearrangement	 in	 inert	 solvents	 like	 benzene,	 toluene	 and	
chloroform,	 forming	 isocyanates.	 In	 the	 presence	 of	 polar	
solvents	 like	 alcohol	 or	 water,	 the	 resulting	 isocyanate	 will	
react	with	these	solvents	to	form	urethans	or	ureas.	Amines	or	
their	 salts	 are	 obtained	 by	 hydrolysis	 of	 the	 isocyanate,	
urethans	 or	 ureas.	 However,	 heating	 of	 the	 carbazide	 33	 in	
toluene	for	3	hours	gives	 the	 isocyanate	derivative	35.	On	the	
other	 hand,	 hydrolysis	 of	 the	 carbazide	 33	 yielded	 the	
corresponding	 3‐amino‐2,6‐dimethylquinoxalin‐1,4‐dioxide	
derivative	36,	which	is	diazotized	and	coupled	with	β–naphthol	
in	alkaline	medium	to	afford	the	corresponding	azo‐β‐naphthol	
derivative	37	(Scheme	13).	
	
	
Scheme	13	
	
4.	Conclusion	
	
We	 could	 prepare	 some	 novel	 benzimidazole	 and	
thiazolidinone	 derivatives	 from	 Benzofuroxan.	 Moreover,	 a	
series	 of	 quinoxalinyl	 1,4‐di‐N‐oxide	 derivatives	 could	 be	
derived	from	quinoxalin‐1,4‐di‐N‐oxides.	Plausible	mechanisms	
to	account	for	the	formation	of	the	products	are	suggested.	All	
the	 reactions	 are	 eco‐friendly,	 no	 heavy	metals	 or	 hazardous	
solvents	(mostly	ethanol	and	acetic	acid)	are	involved.	
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